Epidemiology of Plasmodium vivax malaria in India

American Journal of Tropical Medicine and Hygiene

Volumn 95, Issue , 2016, Pages 108-120

  Anvikar, Anupkumar R ^a   Shah, Naman ^a   Dhariwal, Akshay C ^b   Sonal, Gagan Singh ^b   Pradhan, Madan Mohan ^c   Ghosh, Susanta K ^d   Valecha, Neena ^a  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^b GOVERNMENT OF INDIA   (India)

^c Department of Health and Family Welfare   (India)

^d National Institute of Malaria Research   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT;

CHEMOTHERAPY; DISEASE SURVEILLANCE; HUMAN; INDIA; MALARIA CONTROL; MORTALITY; MOSQUITO VECTOR; PHENOTYPE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PREVALENCE; RELAPSE; REVIEW; URBAN AREA; ANIMAL; ANOPHELES; INCIDENCE; MALARIA, VIVAX; PARASITOLOGY; PHYSIOLOGY;

ANIMALS; ANOPHELES; ANTIMALARIALS; HUMANS; INCIDENCE; INDIA; MALARIA, VIVAX; PLASMODIUM VIVAX;

EID: 85014735471     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.16-0163     Document Type: Review

References (55)

1. World Health Organization, 2015. World Malaria Report 2014. Available at: http://www.who.int/malaria/publications/worldmalaria-report-2015/en/. Accessed July 23, 2016.
2. Directorate of National Vector Borne Disease Control Programme, 2012. Strategic Plan for Malaria Control in India 2012-2017: A Five-Year Strategic Plan. Available at: http://nvbdcp.gov.in/Doc/Strategic-Action-Plan-Malaria-2012-17-Co.pdf. Accessed July 23, 2016.
3. Srivastava HC, Kant R, Bhatt RM, Sharma SK, Sharma VP, 1995. Epidemiological observations on malaria in villages of Buhari PHC, Surat, Gujarat. Indian J Malariol 32: 140-152.
4. Adak T, Sharma VP, Orlov VS, 1998. Studies on the Plasmodium vivax relapse pattern in Delhi, India. Am J Trop Med Hyg 59: 175-179.
5. Adak T, Valecha N, Sharma VP, 2001. Plasmodium vivax polymorphism in a clinical drug trial. Clin Diagn Lab Immunol 8: 891-894.
6. Gogtay NJ, Desai S, Kamtekar KD, Kadam VS, Dalvi SS, Kshirsagar NA, 1999. Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections. Ann Trop Med Parasitol 93: 809-812.
7. Rajgor DD, Gogtay NJ, Kadam VS, Kamtekar KD, Dalvi SS, Chogle AR, Aigal U, Bichile LS, Kain KC, Kshirsagar NA, 2003. Efficacy of a 14-day primaquine regimen in preventing relapses in patients with Plasmodium vivax malaria in Mumbai, India. Trans R Soc Trop Med Hyg 97: 438-440.
8. Yadav RS, Ghosh SK, 2002. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India. J Parasitol 88: 1042-1044.
9. Sinha S, Dua VK, Sharma VP, 1989. Efficacy of 5 day radical treatment of primaquine in Plasmodium vivax cases at the BHEL industrial complex, Hardwar (U.P.). Indian J Malariol 26: 83-86.
10. Dua VK, Sharma VP, 2001. Plasmodium vivax relapses after 5 days of primaquine treatment, in some industrial complexes of India. Ann Trop Med Parasitol 95: 655-659.
11. Singh N, Mishra AK, Sharma VP, 1990. Radical treatment of vivax malaria in Madhya Pradesh, India. Indian J Malariol 27: 55-56.
12. Sharma RC, Gautam AS, 1990. Studies on outbreak of malaria in Muliad village of Kheda district, Gujarat. Indian J Malariol 27: 157-162.
13. Srivastava HC, Sharma SK, Bhatt RM, Sharma VP, 1996. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat. Indian J Malariol 33: 173-179.
14. Prasad RN, Virk KJ, Sharma VP, 1991. Relapse/reinfection patterns of Plasmodium vivax infection: a four year study. Southeast Asian J Trop Med Public Health 22: 499-503.
15. Roy M, Bouma MJ, Ionides EL, Dhiman RC, Pascual M, 2013. The potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW India. PLoS Negl Trop Dis 7: e1979.
16. World Health Organization ROfS-EA, 2007. Anopheline Species Complexes in South and South-East Asia: SEARO Technical Publication No. 57. Available at: http://apps.searo.who.int/pds-docs/B2406.pdf. Accessed July 23, 2016.
17. Directorate of National Vector Borne Disease Control Programme, 2012. Country Monitoring & Evaluation Framework in Malaria Control (NVBDCP). Available at: http://nvbdcp.gov.in/Round-9/M&EFramework.pdf. Accessed July 23, 2016.
18. Pandey A, Gitte SV, 2010. Adherence to malaria diagnostic guidelines in field area of Chattisgarh. Indian J Community Med 35: 520-522.
19. Barua N, Pandav CS, 2011. The allure of the private practitioner: is this the only alternative for the urban poor in India? Indian J Public Health 55: 107-114.
20. Mishra N, Anvikar AR, Shah NK, Kamal VK, Sharma SK, Srivastava HC, Das MK, Pradhan K, Kumar H, Gupta YK, Gupta P, Dash AP, Valecha N, 2011. Prescription practices and availability of artemisinin monotherapy in India: where do we stand? Malar J 10: 360.
21. Kamat V, 2001. Private practitioners and their role in the resurgence of malaria in Mumbai (Bombay) and Navi Mumbai (New Bombay), India: serving the affected or aiding an epidemic? Soc Sci Med 52: 885-909.
22. Srivastava HC, Yadav RS, Joshi H, Valecha N, Mallick PK, Prajapati SK, Dash AP, 2008. Therapeutic responses of Plasmodium vivax and P. Falciparum to chloroquine, in an area of western India where P. Vivax predominates. Ann Trop Med Parasitol 102: 471-480.
23. Singh RK, 2000. Emergence of chloroquine-resistant vivax malaria in south Bihar (India). Trans R Soc Trop Med Hyg 94: 327.
24. Saravu K, Kumar R, Ashok H, Kundapura P, Kamath V, Kamath A, Mukhopadhyay C, 2016. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from primary care centres in southwestern India. PLoS One 11: e0157666.
25. Mishra N, Singh JP, Srivastava B, Arora U, Shah NK, Ghosh SK, Bhatt RM, Sharma SK, Das MK, Kumar A, Anvikar AR, Kaitholia K, Gupta R, Sonal GS, Dhariwal AC, Valecha N, 2012. Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010. Bull World Health Organ 90: 895-904.
26. Mishra N, Srivastava B, Bharti RS, Rana R, Kaitholia K, Anvikar AR, Das MK, Ghosh SK, Bhatt RM, Tyagi PK, Dev V, Phookan S, Wattal SL, Sonal GS, Dhariwal AC, Valecha N, 2016. Monitoring the efficacy of antimalarial medicines in India via sentinel sites: outcomes and risk factors for treatment failure. J Vector Borne Dis 53: 168-178.
27. Directorate of National Vector Borne Disease Control Programme, Directorate of General Health Services, Ministry of Health and Family Welfare Government of India, 2016. National Framework for Malaria Elimination in India (2016-2030). Available at: http://www.nvbdcp.gov.in/Doc/Nationalframework-for-malaria-elimination-in-India-2016%E2%80% 932030.pdf. Accessed July 23, 2016.
28. Bhasin M, 2006. Genetics of castes and tribes of India: glucose-6-phosphate dehydrogenase deficiency and abnormal haemoglobins (HbS and HbE). Int J Hum Genet 6: 49-72.
29. Balgir RS, 2010. Genetic diversity of hemoglobinopathies, G6PD deficiency, and ABO and Rhesus blood groups in two isolates of a primitive Kharia Tribe in Sundargarh District of northwestern Orissa, India. J Community Genet 1: 117-123.
30. Directorate of National Vector Borne Disease Control Programme, 2013. National Drug Policy on Malaria. Available at: http://nvbdcp.gov.in/Doc/National-Drug-Policy-2013.pdf. Accessed July 23, 2016.
31. Baird JK, 2015. Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency. BMC Med 13: 296.
32. Director of Health Services (Malaria), 2011. Annual Report on Implementation of National Vector Borne Disease Control Programme (NVBDCP) in Haryana State. Available at: http://haryanahealth.nic.in/userfiles/file/pdf/New%20Malaria%202013/Annual%20Report%20on%20implementation%20of%20NVBD CP%202011-15042013.pdf. Accessed July 23, 2016.
33. Acharya A, Magisetty J, Chandra A, Chaithra B, Khanum T, Vijayan V, 2013. Trend of malaria incidence in the state of Karnataka, India for 2001 to 2011. Archives of Applied Science Research 5: 104-111.
34. Hati AK, 1997. Urban malaria vector biology. Indian J Med Res 106: 149-163.
35. Parizo J, Sturrock HJ, Dhiman RC, Greenhouse B, 2016. Spatiotemporal analysis of malaria in urban Ahmedabad (Gujarat), India: identification of hot spots and risk factors for targeted intervention. Am J Trop Med Hyg 95: 595-603.
36. Ghosh SK, Tiwari S, Ojha VP, 2012. A renewed way of malaria control in Karnataka, south India. Front Physiol 3: 194.
37. Directorate of National Vector Borne Disease Control Programme, 2012. Urban Malaria Scheme and Other Vector Borne Disease Control Programme. Available at: http://www.nvbdcp.gov.in/Doc/Proceeding%20of%20UMS%20Report%209-7-12.pdf. Accessed July 23, 2016.
38. Joshi U, Solanki A, Oza U, Bhatt R, Vyas S, Patel P, Rana A, Dabhi L, 2013. Situation of P. Vivax malaria in Ahmedabad city: a study in purview of national guidelines. Ann Trop Med Public Health 6: 227-231.
39. Srivastava HC, Pant C, Sreehari U, Yadav RS, 2011. Malaria in seasonal migrant population in southern Gujurat, India. Trop Biomed 28: 638-645.
40. Tiwari S, Kumar Ghosh S, Sathyanarayan T, Nanda N, Uragayala S, Valecha N, 2015. Malaria outbreaks in villages in North Karnataka, India, and role of sibling species of Anopheles culicifacies complex. Health 7: 946-954.
41. Tripathy A, Samanta L, Das S, Parida SK, Marai N, Hazra RK, Kar SK, Mahapatra N, 2010. Distribution of sibling species of Anopheles culicifacies s.l. and Anopheles fluviatilis s.l. and their vectorial capacity in eight different malaria endemic districts of Orissa, India. Mem Inst Oswaldo Cruz 105: 981-987.
42. Kumari S, Parida SK, Marai N, Tripathy A, Hazra RK, Kar SK, Mahapatra N, 2009. Vectorial role of anopheles subpictus Grassi and anopheles culicifacies Giles in Angul District, Orissa, India. Southeast Asian J Trop Med Public Health 40: 713-719.
43. Mahapatra N, Marai N, Dhal K, Nayak R, Panigrahi B, Mallick G, Ranjit M, Kar S, Kerketta A, 2012. Malaria outbreak in a non endemic tribal block of Balasore district, Orissa, India during summer season. Trop Biomed 29: 277-285.
44. Chaudhari KS, Uttarwar SP, Tambe NN, Sharma RS, Takalkar AA, 2016. Role of serum lactate and malarial retinopathy in prognosis and outcome of falciparum and vivax cerebral malaria: a prospective cohort study in adult Assamese tribes. J Glob Infect Dis 8: 61-67.
45. Chauhan V, Raina SK, Thakur S, 2016. State of the globe: the resurgence of vivax. J Glob Infect Dis 8: 59-60.
46. Gupta A, Dhume V, Puranik GV, Kavishwar V, 2015. Autopsy study of febrile deaths during monsoon at a tertiary care institute in India: is malaria still a challenge? Niger Med J 56: 6-11.
47. Gupta P, Sharma R, Chandra J, Kumar V, Singh R, Pande V, Singh V, 2016. Clinical manifestations and molecular mechanisms in the changing paradigm of vivax malaria in India. Infect Genet Evol 39: 317-324.
48. Hupalo DN, Luo Z, Melnikov A, Sutton PL, Rogov P, Escalante A, Vallejo AF, Herrera S, Arevalo-Herrera M, Fan Q, Wang Y, Cui L, Lucas CM, Durand S, Sanchez JF, Baldeviano GC, Lescano AG, Laman M, Barnadas C, Barry A, Mueller I, Kazura JW, Eapen A, Kanagaraj D, Valecha N, Ferreira MU, Roobsoong W, Nguitragool W, Sattabonkot J, Gamboa D, Kosek M, Vinetz JM, Gonzalez-Ceron L, Birren BW, Neafsey DE, Carlton JM, 2016. Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax. Nat Genet 48: 953-958.
49. Wassmer SC, Taylor TE, Rathod PK, Mishra SK, Mohanty S, Arevalo-Herrera M, Duraisingh MT, Smith JD, 2015. Investigating the pathogenesis of severe malaria: a multidisciplinary and cross-geographical approach. Am J Trop Med Hyg 93: 42-56.
50. Dhingra N, Jha P, Sharma VP, Cohen AA, Jotkar RM, Rodriguez PS, Bassani DG, Suraweera W, Laxminarayan R, Peto R; Million Death Study Collaborators, 2010. Adult and child malaria mortality in India: a nationally representative mortality survey. Lancet 376: 1768-1774.
51. Basnyat B, 2011. Malaria-attributed death rates in India. Lancet 377: 993; author reply 994-995.
52. Deonarine A, 2011. Malaria-attributed death rates in India. Lancet 377: 993-994; author reply 994-995.
53. Kumar A, Dua VK, Rathod PK, 2011. Malaria-attributed death rates in India. Lancet 377: 991-992; author reply 994-995.
54. Shah NK, Dhariwal AC, Sonal GS, Gunasekar A, Dye C, Cibulskis R, 2011. Malaria-attributed death rates in India. Lancet 377: 991; author reply 994-995.
55. Valecha N, Staedke S, Filler S, Mpimbaza A, Greenwood B, Chandramohan D, 2011. Malaria-attributed death rates in India. Lancet 377: 992-993; author reply 994-995.